Increasing use of antidepressants in pregnancy.

Am J Obstet Gynecol

Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, TN 37232-2504, USA.

Published: June 2007

Objective: The purpose of this study was to quantify the rate of exposures to antidepressants during pregnancy in a large cohort of women.

Study Design: This was a retrospective cohort study of 105,335 pregnancies among women enrolled in Tennessee Medicaid from 1999-2003. Pregnancies were classified according to antidepressant exposures during pregnancy using previously validated computerized pharmacy records linked with birth certificates.

Results: During the study period, 8.7% of women giving birth had exposure to any antidepressant; 6.2% had exposure to a selective serotonin reuptake inhibitor. Maternal age > 25 years (P < .0001), white race (P < .0001), and education > 12 years (P = .008) were significant predictors of antidepressant exposure. The proportion of pregnancies with antidepressant use increased from 5.7% of pregnancies in 1999 to 13.4% of pregnancies in 2003 (p < .0001). The increase was mostly accounted for by increases in selective serotonin reuptake inhibitor exposures.

Conclusion: There is an urgent need for further studies that better quantify the fetal consequences of exposure to antidepressants.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajog.2007.01.033DOI Listing

Publication Analysis

Top Keywords

antidepressants pregnancy
8
selective serotonin
8
serotonin reuptake
8
reuptake inhibitor
8
pregnancies
5
increasing antidepressants
4
pregnancy objective
4
objective purpose
4
purpose study
4
study quantify
4

Similar Publications

Background: While electroconvulsive therapy and antidepressants are standard treatments for depressed pregnant women, they are not without threats. The objective of this study was to quantitative synthesis of the literature regarding the effect of yoga interventions on depressive symptoms in pregnant women.

Methods: Nine electronic databases were searched for primary studies with pregnant women with depression measured as outcomes and written in English.

View Article and Find Full Text PDF

Pinelliae Rhizoma: a systematic review on botany, ethnopharmacology, phytochemistry, preclinical and clinical evidence.

Chin J Nat Med

January 2025

Macao Centre for Research and Development in Chinese Medicine, State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao SAR 999078, China. Electronic address:

Pinelliae Rhizoma (PR), known as Banxia in Chinese, Hange in Japanese, and Banha in Korean, is a renowned herbal medicine in East Asia derived from the dry tuber of Pinellia ternata (Thunb.) Breit. (PT).

View Article and Find Full Text PDF

Mental health conditions during pregnancy, especially postpartum depression (PPD), can have profound and long-lasting effects on the individual, impeding her ability to bond with her child and disrupting the family dynamics. Although pharmacological treatments like antidepressants are the mainstay treatment options, several mothers have concerns about their safety and potential side effects, especially breastfeeding mothers. There is an emerging interest in exploring the use of non-pharmacological interventions as an alternative treatment modality for PPD.

View Article and Find Full Text PDF

Background: Fluoxetine is commonly prescribed to treat depression during pregnancy. We aimed to evaluate the effects of prenatal fluoxetine exposure on maternal-offspring behavior in a non-depressed sheep model.

Methods: On day 119 ± 1 of a 151-day expected gestation, Hampshire ewes were randomly assigned to receive intravenous fluoxetine (10 mg/kg for the first 2 days and 5 mg/kg daily thereafter until parturition) or a control vehicle.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!